Group A streptococcus necrotising fasciitis from a levonorgestrel-containing intrauterine system ('Mirena' coil)

被引：1

作者：

Saleh, S. ^{[1
]}

Ahmad, G. ^{[2
]}

Majumdar, A. ^{[3
]}

机构：

[1] Blackpool Victoria Hosp, Dept Obstet & Gynaecol, Blackpool FY3 8NR, Lancs, England

[2] Burnley Gen Hosp, Burnley, Lancs, England

[3] Royal Blackburn Hosp, Blackburn, Lancs, England

来源：

JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2011年 / 31卷 / 02期

关键词：

SOFT-TISSUE INFECTIONS; MORTALITY;

D O I：

10.3109/01443615.2010.529962

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：192 / 194

页数：4

共 50 条

[41] The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities
Pillai, M.
O'Brien, K.
Hill, E.
[J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (02) : 216 - 221
[42] Risk-Adapted Approach to Levonorgestrel-Containing Intrauterine Devices Placement for Heavy Menstrual Bleeding in Adolescents With Bleeding Disorders
Fiorillo, Megan H.
Cygan, Peter H.
Wright, Tonya
[J]. OBSTETRICS AND GYNECOLOGY, 2022, 139 : 27S - 28S
[43] Caregiver Knowledge of and Attitudes Toward the Levonorgestrel-Containing Intrauterine Device for the Treatment of Heavy Menstrual Bleeding in Adolescents and Young Adults
Juhel, H. S.
Acharya, S. S.
Appelbaum, H.
[J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2022, 35 (02) : 153 - 158
[44] Case Report of the Successful Use of Mirena Levonorgestrel Intrauterine System in a Patient with Didelphys Uterus and Ostructed Hemivagina
King, Carol P.
Kives, Sari
[J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2019, 32 (02) : 182 - 185
[45] Necrotising fasciitis caused by invasive group A Streptococcus after trans-obturator tape placement
Mathoera, R. B.
Wever, P. C.
van den Aker, E.
de Jager, C. P. C.
[J]. NETHERLANDS JOURNAL OF CRITICAL CARE, 2007, 11 (05): : 267 - 269
[46] Evaluation of Quality of Life and Sexual Functioning of Women Using Levonorgestrel-Releasing Intrauterine Contraceptive System - Mirena
Skrzypulec, Violetta
Drosdzol, Agnieszka
[J]. COLLEGIUM ANTROPOLOGICUM, 2008, 32 (04) : 1059 - 1068
[47] Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial
Jensen, Jeffrey T.
Lukkari-Lax, Eeva
Schulze, Andrea
Wahdan, Yesmean
Serrani, Marco
Kroll, Robin
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (06) : 873.e1 - 873.e12
[48] Necrotising fasciitis and group A streptococcus toxic shock-like syndrome in pregnancy: treatment with plasmapheresis and immunoglobulin
Simmonds, M
[J]. INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 1999, 8 (02) : 125 - 130
[49] The effect of the levonorgestrel-releasing intrauterine system, Mirena® on mast cell numbers in women with endometriosis undergoing symptomatic treatment
Engemise, Samuel L.
Willets, Jonathon M.
Emembolu, Joseph O.
Konje, Justin C.
[J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 159 (02) : 439 - 442
[50] Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women
Jozwik, Maciej
Jozwik, Marcin
Modzelewska, Beata
Niewinska, Marta
Jozwik, Michal
[J]. GINEKOLOGIA POLSKA, 2015, 86 (04) : 305 - 310

← 1 2 3 4 5 →